Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Atypical Immunophenotype Predicts Worse Prognosis in Adult T-Cell Lymphoma/Leukemia: A Retrospective Study of 63 Caribbean Patients at a New York City Tertiary Center

Bachar Samra, MD, Edwin Chiu, MD, Bo Lin, MD PhD, Eric Tam, MD BS, Babak Baseri, MD MS, Iuliana Shapira, MD, Jason Gonsky, MD PhD, Robert David Lewis, MD, Gurinder Sidhu, MD, Ahmed Sawas, MD, Evelyn O. Taiwo, MD

Blood (2018) 132 (Supplement 1): 2906.

https://doi.org/10.1182/blood-2018-99-111208

Published: 2018

Journal Articles

SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease

Robert Swift, PhD, Osheiza Abdulmalik, DVM, MS, Qiukan Chen, Toshio Asakura, MD PhD, Kelsey Gustafson, MS, James E Simon, PhD, Virdah Zaman, MS, Kevin Alexis Quiusky, MD, Kathryn L. Hassell, MD, Iuliana Shapira, MD, Gurinder Sidhu, MD, Tracian James-Goulbourne, MD, Kisha Carrington, MD, John Muthu, MD, Peter N Gillette, MD

Blood (2016) 128 (22): 121.

https://doi.org/10.1182/blood.V128.22.121.121

Published: 2016

Journal Articles

Comparison of Disposition and Complications in Geriatric (≥ 65 years) and Non-Geriatric (50-64 years) Cancer Patients Receiving Hematopoietic Stem Cell Transplantation

Achuta Kumar Guddati, MD PhD, Gagan Kumar, MD MS, Robert David Lewis, MD, Iuliana Shapira, MD

Blood (2016) 128 (22): 2408.

https://doi.org/10.1182/blood.V128.22.2408.2408

Published: 2016

Journal Articles

A Critical Analysis of Prognostic Factors in Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma: A Multicenter Clinicopathologic Experience and New Prognostic Score.

Adrienne A. Phillips, MD, MPH, Iuliana Shapira, MD, Robert D. Willum, BS, Jasotha Sanmugarajah, MD, William B. Solomon, MD, Steven M. Horwitz, MD, David G. Savage, MD, Govind Bhagat, MD, Gerald Soff, MD, Jasmine M. Zain, MD, Bashir Alobeid, MD, Venkatraman E. Seshan, PhD, Owen A. O’Connor, MD, PhD

Blood (2008) 112 (11): 1784.

https://doi.org/10.1182/blood.V112.11.1784.1784

Published: 2008

Journal Articles

A Multicenter Clinicopathologic Experience of HTLV-1 ATLL: A Retrospective 15 Year Review Reveals Little Progress.

Adrienne A. Phillips, MD, MPH, Iuliana Shapira, MD, Robert D. Willim, BS, Jasotha Sanmugarajah, MD, William B. Solomon, MD, Steven M. Horwitz, MD, David G. Savage, MD, Gerald Soff, MD, Owen A. O’Connor, MD, PhD

Blood (2007) 110 (11): 3569.

https://doi.org/10.1182/blood.V110.11.3569.3569

Published: 2007

Journal Articles

Infusional Adriamycin Based Chemotherapy Significantly Improves the Survival of Human T-Cell Lymphotropic Virus-I Induced Acute Type Adult T-Cell Leukemia Lymphoma.

Daniel Efiom-Ekaha, MD, Joseph Feldman, Susan Gottesman, MD, Natalya Krichmar, MD, Olugbenga Olowokure, Jasotha Sanmugaharajah, MD, Iuliana Shapira, MD, William B. Solomon, MD, Emily Qian Chen, MD

Blood (2005) 106 (11): 2684.

https://doi.org/10.1182/blood.V106.11.2684.2684

Published: 2005

Journal Articles

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Low-Dose Thalidomide in Combination with Dexamethasone and Zoledronate: A Phase II Trial.

Uwe Klueppelberg, MD, PhD, Iuliana Shapira, MD, Eric Smith, PhD, Marc Braunstein, BS, David Kahn, MD, Yury Pertsovsky, Olcay Batuman, MD

Blood (2005) 106 (11): 5180.

https://doi.org/10.1182/blood.V106.11.5180.5180

Published: 2005

Journal Articles

Poor Survival in ATL Patients Treated with CHOP Chemotherapy.

Iuliana Shapira, MD, Joseph Feldman, MD, William B. Solomon, MD

Blood (2004) 104 (11): 4575.

https://doi.org/10.1182/blood.V104.11.4575.4575

Published: 2004

Journal Articles

First-Line Treatment of Multiple Myeloma with a Combination of Thalidomide, Dexamethasone, and Zoledronate (TDZ) in an Inner-City Population with High HIV Prevalence.

Uwe Klueppelberg, MD PhD, Eric Smith, PhD, Laurie Chen, MD, Chona M. Aloba, MD, Iuliana Shapira, MD, Mehdi M. Moezi, MD, Olcay Batuman, MD

Blood (2004) 104 (11): 4932.

https://doi.org/10.1182/blood.V104.11.4932.4932

Published: 2004

NARROW

Atypical Immunophenotype Predicts Worse Prognosis in Adult T-Cell Lymphoma/Leukemia: A Retrospective Study of 63 Caribbean Patients at a New York City Tertiary Center

SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease

Comparison of Disposition and Complications in Geriatric (≥ 65 years) and Non-Geriatric (50-64 years) Cancer Patients Receiving Hematopoietic Stem Cell Transplantation

A Critical Analysis of Prognostic Factors in Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma: A Multicenter Clinicopathologic Experience and New Prognostic Score.

A Multicenter Clinicopathologic Experience of HTLV-1 ATLL: A Retrospective 15 Year Review Reveals Little Progress.

Infusional Adriamycin Based Chemotherapy Significantly Improves the Survival of Human T-Cell Lymphotropic Virus-I Induced Acute Type Adult T-Cell Leukemia Lymphoma.

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Low-Dose Thalidomide in Combination with Dexamethasone and Zoledronate: A Phase II Trial.

Poor Survival in ATL Patients Treated with CHOP Chemotherapy.

First-Line Treatment of Multiple Myeloma with a Combination of Thalidomide, Dexamethasone, and Zoledronate (TDZ) in an Inner-City Population with High HIV Prevalence.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only